Mechanisms underlying renoprotection during renin-angiotensin system blockade. - sprookjes - yvandenbroek - TriplyDB

Mechanisms underlying renoprotection during renin-angiotensin system blockade.

Mechanisms underlying renoprotection during renin-angiotensin system blockade.

http://www.wikidata.org/entity/Q32032668

about

Delayed mTOR inhibition with low dose of everolimus reduces TGFβ expression, attenuates proteinuria and renal damage in the renal mass reduction model Urinary monocyte chemoattractant protein-1 and hepcidin and early diabetic nephropathy lesions in type 1 diabetes mellitus.Low-protein diet supplemented with ketoacids reduces the severity of renal disease in 5/6 nephrectomized rats: a role for KLF15.Health Education and General Practitioner Training in Hypertension Management: Long-Term Effects on Kidney Function Atorvastatin treatment attenuates renal injury in an experimental model of ischemia-reperfusion in rats.Intratubular Renin-Angiotensin System in Hypertension.

P2860

Q28731390-7C7099FD-2C3C-4ADD-8B2F-29B63FB0C1CF Q35474328-AE0E7F39-4A38-4207-BAE3-0A9EF228172C Q35903779-91257047-2DBB-49D8-91C4-B6BE9BB5FE1F Q36965095-8962DDCC-C9AA-44F4-979F-0A97B2D48D2C Q41883287-965408D9-AD3D-4B49-B398-2FF6CCE9E368 Q55717949-BF2F3BA8-E8C2-4F8E-BB34-A9C9777112EE

P2860

Mechanisms underlying renoprotection during renin-angiotensin system blockade.

http://www.wikidata.org/entity/Q32032668

description

2001 nî lūn-bûn

@nan

2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2001 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2001年の論文

@ja

2001年論文

@yue

2001年論文

@zh-hant

2001年論文

@zh-hk

2001年論文

@zh-mo

2001年論文

@zh-tw

2001年论文

@wuu

name

Mechanisms underlying renoprotection during renin-angiotensin system blockade.

@ast

Mechanisms underlying renoprotection during renin-angiotensin system blockade.

@en

type

label

Mechanisms underlying renoprotection during renin-angiotensin system blockade.

@ast

Mechanisms underlying renoprotection during renin-angiotensin system blockade.

@en

prefLabel

Mechanisms underlying renoprotection during renin-angiotensin system blockade.

@ast

Mechanisms underlying renoprotection during renin-angiotensin system blockade.

@en

P1433

Q32032668-A40E6D6C-C7FF-4CF0-A8D5-2E6FD16EF3B6

P1476

Q32032668-12D29473-1E4A-40B8-A9A8-625D17039A72

P2093

Q32032668-160695C5-1369-422D-B4FE-CEB493A9AE12

Q32032668-5C6DB6E6-55D7-4020-9EE3-D989A8BEEA55

Q32032668-811326DA-32BA-42CD-9797-83204050FA21

Q32032668-8175644F-70F0-4818-B43B-712B75FF2D36

Q32032668-8459B911-86C7-45B3-9487-432848AAC350

Q32032668-96C43900-5A41-48B5-9A17-B094CCCC1987

Q32032668-B4792FC3-FBAB-4506-A285-45B366DDF5F3

Q32032668-C0369B75-2FC6-48A5-91F7-428AC9C4AA19

P2860

Q32032668-0401C851-96FC-495C-8870-5F5A1320219A

Q32032668-140E902C-E00F-43FF-9574-EB00017094D3

Q32032668-1E0C7325-1920-4326-A686-2ADF1BF179A5

Q32032668-1F28C9F6-7529-4C9E-874C-70438C8B72AB

Q32032668-2876C11B-36CB-43BB-88A3-F3354BCAB803

Q32032668-2A10CDB1-6838-45D5-9B51-E798D646C9C1

Q32032668-388B0BF1-89B5-47B8-9DCF-936D2496E05D

Q32032668-5CE48C35-062E-47E6-BDF3-9A03FCBC7718

Q32032668-623A808A-1181-4C90-B0F5-CE1849A79BBA

Q32032668-644FF538-15D3-4E71-AB39-839592D1A3F8

P304

Q32032668-8945B87F-3346-4815-88BE-874BA7A43E8A

P31

Q32032668-3A954CF9-0F5C-4482-A387-FC038E8A0282

P356

Q32032668-5E8C1DB1-A204-4AF2-832C-112A5201CC87

P433

Q32032668-C0DAB404-DA09-4501-9957-34214B1A0B56

P478

Q32032668-C828E771-A258-429D-9954-CB3BE57AE4BD

P50

Q32032668-07075F10-2BB0-462A-AFFB-8F8A23B0570D

P577

Q32032668-265C2E8C-B151-4BE4-AF6A-583B323C30FC

P698

Q32032668-59802D5C-3089-435A-AFF5-D6A1A7D06CA5

P356

AJPRENAL.2001.280.2.F343

P1433

American Journal of Physiology - Renal Physiology

P1476

Mechanisms underlying renoprotection during renin-angiotensin system blockade

@en

P2093

A Gurnani

http://www.w3.org/2001/XMLSchema#string

A Shahsafaei

http://www.w3.org/2001/XMLSchema#string

B M Brenner

http://www.w3.org/2001/XMLSchema#string

G M Chertow

http://www.w3.org/2001/XMLSchema#string

H G Rennke

http://www.w3.org/2001/XMLSchema#string

H S Mackenzie

http://www.w3.org/2001/XMLSchema#string

J L Troy

http://www.w3.org/2001/XMLSchema#string

T Jiang

http://www.w3.org/2001/XMLSchema#string

P2860

Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease

Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass

Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat

Renoprotective benefits of RAS inhibition: from ACEI to angiotensin II antagonists.

Cellular and molecular mediators in common pathway mechanisms of chronic renal disease progression.

The cis-acting phorbol ester "12-O-tetradecanoylphorbol 13-acetate"-responsive element is involved in shear stress-induced monocyte chemotactic protein 1 gene expression

Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells.

Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria.

Renal function and requirement for dialysis in chronic nephropathy patients on long-term ramipril: REIN follow-up trial. Gruppo Italiano di Studi Epidemiologici in Nefrologia (GISEN). Ramipril Efficacy in Nephropathy.

Fluid shear stress induces endothelial transforming growth factor beta-1 transcription and production. Modulation by potassium channel blockade.

P304

F343-55

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1152/AJPRENAL.2001.280.2.F343

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

280

http://www.w3.org/2001/XMLSchema#string

P50

P577

2001-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11208610

http://www.w3.org/2001/XMLSchema#string